Prosecution Insights
Last updated: April 19, 2026
Application No. 18/353,077

ASPIRATION MONITORING SYSTEM AND METHOD

Non-Final OA §102§103§DP
Filed
Jul 15, 2023
Examiner
RASSAVONG, ERIC
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Incuvate LLC
OA Round
2 (Non-Final)
72%
Grant Probability
Favorable
2-3
OA Rounds
2y 5m
To Grant
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allow Rate
110 granted / 152 resolved
+2.4% vs TC avg
Strong +33% interview lift
Without
With
+33.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
56 currently pending
Career history
208
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
53.4%
+13.4% vs TC avg
§102
23.2%
-16.8% vs TC avg
§112
14.5%
-25.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 152 resolved cases

Office Action

§102 §103 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-2, 4-6, and 11-13 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 3-6 of U.S. Patent No. 11744600 . Claims 1-2, 4-6 and 11-13 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 3-6 of U.S. Patent No. 10702292. Although the claims at issue are not identical, they are not patentably distinct from each other because all limitations in the current claims can be found in the patented claims, as shown in the chart below. Current claim # 1 2 4 5 6 11 12 13 Corresponding claim # in 11744600 3, 6 3, 6 3 6 3, 6 3 6 3, 6 Current claim # 1 2 4 5 6 11 12 13 Corresponding claim # in 10702292 3-6 3-6 3, 4 5, 6 6 3, 4 5, 6 6 Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2, 4, 6-11, 13-20, and 22-23 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Tiedtke et al. (US 20040153109 A1), hereinafter after referred to as “Tiedtke”. Regarding Claim 1, Tiedtke teaches a system for real time monitoring of catheter aspiration (see Abstract; Figure 3), comprising: a pressure sensor (414) configured for placement in fluid communication with a lumen (return lumen 438) which at least partially includes an aspiration lumen of a catheter (lumen of catheter 402), the aspiration lumen configured to couple to a vacuum source (440); a processor coupled to the pressure sensor (electronic signal evaluation circuit 442, see Figure 3) and configured for measuring deviations in fluid pressure (the pressure sensor 414 measures the pressure drop over the hydraulic resistance. The measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]-[0022]; it is understood the evaluation device collects data from sensor 414); and a communicator coupled to the processor (an acoustic signal generator 446, see Figure 3) and configured to generate a continuous signal which is proportional to measured fluid pressure (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]), the continuous signal provided by a non-visual source (acoustic signal generator 446). Regarding Claim 2, Tiedtke teaches a system for real time monitoring of catheter aspiration (see Abstract; Figure 3), comprising: a pressure sensor (414) configured for placement in fluid communication with an aspiration lumen (return lumen 438) of a catheter (catheter 402), the aspiration lumen configured to couple to a vacuum source (440); a processor coupled to the pressure sensor (electronic signal evaluation circuit 442, see Figure 3) and configured for measuring variations in fluid pressure (the pressure sensor 414 measures the pressure drop over the hydraulic resistance. The measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]-[0022]; it is understood the evaluation device collects data from sensor 414); and a communicator coupled to the processor (an acoustic signal generator 446, see Figure 3) and configured to generate a continuous signal which varies proportionally as a result of variation in fluid pressure (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]), the continuous signal provided by a non-visual source (acoustic signal generator 446). Regarding Claim 4, Tiedtke further teaches wherein the continuous signal is provided by an audible source (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 6, Tiedtke further teaches wherein the communicator comprises an audio speaker, a piezoelectric, a heater, or a vibrator (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 7, Tiedtke further teaches wherein an amplitude of the continuous signal is proportional to the measured fluid pressure (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 8, Tiedtke further teaches wherein a frequency of the continuous signal is proportional to the measured fluid pressure (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 9, Tiedtke further teaches wherein the proportionality is direct proportionality (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 10, Tiedtke further teaches wherein the catheter further includes a high pressure injection lumen (430) having a proximal end (404) and a distal end (406) and extending from a proximal end of the catheter to a location adjacent a distal end of the aspiration lumen (see Figure 3); and at least one orifice at or near the distal end of the high pressure injection lumen (a path section 432 open to the outside surroundings on the distal end section 406 of the catheter, see Figure 3) and configured to allow high pressure liquid injected through the high pressure injection lumen to be released into the aspiration lumen (the pressurized fluid arrives at the distal end section 406 of catheter 402 in the form of a sharp fluid jet in the open path section 432, treats the vessel 12 there, for example, cuts or fragments the vascular constriction material 434 and then flows into the distal end 436 of the return channel 438 with entrainment of material 434 and then through the latter in the direction of arrow 418 to the proximal end section 404, see Paragraph [0020]). Regarding Claim 11, Tiedtke further teaches wherein the continuous signal is provided by an audible source (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 13, Tiedtke teaches wherein the communicator comprises an audio speaker, a piezoelectric, a heater, or a vibrator (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 14, Tiedtke further teaches wherein an amplitude of the continuous signal is proportional to the measured fluid pressure (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 15, Tiedtke further teaches wherein a frequency of the continuous signal is proportional to the measured fluid pressure (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 16, Tiedtke further teaches wherein the proportionality is direct proportionality (the measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]). Regarding Claim 17, Tiedtke further teaches wherein the catheter further includes a high pressure injection lumen (430) having a proximal end (404) and a distal end (406) and extending from a proximal end of the catheter to a location adjacent a distal end of the aspiration lumen (see Figure 3); and at least one orifice at or near the distal end of the high pressure injection lumen (a path section 432 open to the outside surroundings on the distal end section 406 of the catheter, see Figure 3) and configured to allow high pressure liquid injected through the high pressure injection lumen to be released into the aspiration lumen (the pressurized fluid arrives at the distal end section 406 of catheter 402 in the form of a sharp fluid jet in the open path section 432, treats the vessel 12 there, for example, cuts or fragments the vascular constriction material 434 and then flows into the distal end 436 of the return channel 438 with entrainment of material 434 and then through the latter in the direction of arrow 418 to the proximal end section 404, see Paragraph [0020]). Regarding Claim 18, Tiedtke teaches a system for real time monitoring of thrombus aspiration (see Abstract; Figure 3), comprising: a pressure sensor (414) configured for placement in fluid communication with an aspiration lumen (return lumen 438) of a catheter (catheter 402) and configured to measure pressure within the aspiration lumen to characterize flow of blood and/or thrombus within the aspiration lumen (the pressure sensor 414 measures the pressure drop over the hydraulic resistance. The measured pressure varies as a function of flow resistance of the fluid in the flow path of the catheter, see Paragraph [0020]-[0022]; it is understood the evaluation device collects data from sensor 414), the aspiration lumen configured to couple to a vacuum source (440); a processor coupled to the pressure sensor (electronic signal evaluation circuit 442, see Figure 3) and configured for continuously measuring fluid pressure (it is understood the evaluation device collects data from sensor 414); and a communicator coupled to the processor to receive output therefrom ( an optical display device 444 and/or to an acoustic signal generator 446, see Figure 3), and configured to generate a continuous signal that is not a pseudo-continuous analog (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]), of which a physical property is proportional to measured fluid pressure and of which a physical property can be sensed real- time by a user for characterizing fluid pressure (the optical display device 444 shows the user of catheter 402 the aforementioned information; the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 19, Tiedtke further teaches wherein the continuous signal is provided by a visual source (optical display device 444). Regarding Claim 20, Tiedtke further teaches wherein the continuous signal is provided by an audible source (the acoustic signal generator 446 generates tones or noises that the user can hear, depending on the information, see Paragraph [0021]). Regarding Claim 22, Tiedtke further teaches wherein the continuous signal is provided by a non-visual source (the pressure sensor 414 is connected via an electronic signal evaluation circuit 442 to the acoustic signal generator 446, see Paragraph [0021]). Regarding Claim 23, Tiedtke further teaches wherein the catheter further includes a high pressure injection lumen (430) having a proximal end (404) and a distal end (406) and extending from a proximal end of the catheter to a location adjacent a distal end of the aspiration lumen (see Figure 3); and at least one orifice at or near the distal end of the high pressure injection lumen (a path section 432 open to the outside surroundings on the distal end section 406 of the catheter, see Figure 3) and configured to allow high pressure liquid injected through the high pressure injection lumen to be released into the aspiration lumen (the pressurized fluid arrives at the distal end section 406 of catheter 402 in the form of a sharp fluid jet in the open path section 432, treats the vessel 12 there, for example, cuts or fragments the vascular constriction material 434 and then flows into the distal end 436 of the return channel 438 with entrainment of material 434 and then through the latter in the direction of arrow 418 to the proximal end section 404, see Paragraph [0020]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 5, 12, and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Pratt et al. (US 20150094673 A1), hereinafter referred to as “Pratt”. Regarding Claim 5, Tiedtke teaches all of the limitations as discussed above in claim 1. However, Tiedtke does not explicitly disclose wherein the continuous signal is provided by a tactile source. Pratt teaches an apparatuses for providing feedback for reduced-pressure therapy (see Abstract) comprising a pressure sensor (504) coupled to a processor (printed circuit board 502); a communicator coupled to the processor and configured to generate a continuous signal which varies proportionally as a result of variation in fluid pressure (feedback system (500) having a signal interface may be an auditory device or a tactile device, such as a moving protrusion, see Paragraph [0080]; The feedback system may further include an indicator communicatively coupled to the printed circuit board and the pressure sensor, and may be configured to indicate a status of the control pressure, see Paragraph [0007]), wherein the continuous signal is provided by a tactile source (a tactile device, such as a moving protrusion, see Paragraph [0080]). Tiedtke and Pratt are analogous art because both teach a monitoring device for providing feedback to user. It would have been obvious to a person having ordinary skill in the art before the effective filling date of the invention to modify the audio communicator device of Tiedtke and replace it with a tactile communicator device of Pratt. Pratt teaches the devices and systems described herein may provide feedback to an operator on leak conditions, feedback to an operator on blockage conditions, and feedback to an operator on canister full conditions (see Paragraph [0117]). Regarding Claim 12, Tiedtke teaches all of the limitations as discussed above in claim 2. However, Tiedtke does not explicitly disclose wherein the continuous signal is provided by a tactile source. Pratt teaches an apparatuses for providing feedback for reduced-pressure therapy (see Abstract) comprising a pressure sensor (504) coupled to a processor (printed circuit board 502); a communicator coupled to the processor and configured to generate a continuous signal which varies proportionally as a result of variation in fluid pressure (feedback system (500) having a signal interface may be an auditory device or a tactile device, such as a moving protrusion, see Paragraph [0080]; The feedback system may further include an indicator communicatively coupled to the printed circuit board and the pressure sensor, and may be configured to indicate a status of the control pressure, see Paragraph [0007]), wherein the continuous signal is provided by a tactile source (a tactile device, such as a moving protrusion, see Paragraph [0080]). Tiedtke and Pratt are analogous art because both teach a monitoring device for providing feedback to user. It would have been obvious to a person having ordinary skill in the art before the effective filling date of the invention to modify the audio communicator device of Tiedtke and replace it with a tactile communicator device of Pratt. Pratt teaches the devices and systems described herein may provide feedback to an operator on leak conditions, feedback to an operator on blockage conditions, and feedback to an operator on canister full conditions (see Paragraph [0117]). Regarding Claim 21, Tiedtke teaches all of the limitations as discussed above in claim 18. However, Tiedtke does not explicitly disclose wherein the continuous signal is provided by a tactile source. Pratt teaches an apparatuses for providing feedback for reduced-pressure therapy (see Abstract) comprising a pressure sensor (504) coupled to a processor (printed circuit board 502); a communicator coupled to the processor and configured to generate a continuous signal which varies proportionally as a result of variation in fluid pressure (feedback system (500) having a signal interface may be an auditory device or a tactile device, such as a moving protrusion, see Paragraph [0080]; The feedback system may further include an indicator communicatively coupled to the printed circuit board and the pressure sensor, and may be configured to indicate a status of the control pressure, see Paragraph [0007]), wherein the continuous signal is provided by a tactile source (a tactile device, such as a moving protrusion, see Paragraph [0080]). Tiedtke and Pratt are analogous art because both teach a monitoring device for providing feedback to user. It would have been obvious to a person having ordinary skill in the art before the effective filling date of the invention to modify the communicator device of Tiedtke and replace it with a tactile communicator device of Pratt. Pratt teaches the devices and systems described herein may provide feedback to an operator on leak conditions, feedback to an operator on blockage conditions, and feedback to an operator on canister full conditions (see Paragraph [0117]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Hochman (US 20140012226 A1) teaches a system for real time monitoring of catheter aspiration (see Figure 1; Paragraph [0001]), comprising: a pressure sensor (20, see Paragraph [0020]) configured for placement in fluid communication with a lumen which at least partially includes an aspiration lumen of a catheter, the aspiration lumen configured to couple to a vacuum source (18); a processor (see Figure 2; Paragraph [0029]) coupled to the pressure sensor and configured for measuring deviations in fluid pressure; and a communicator coupled to the processor (microprocessor 82, see Figure 4) and configured to generate a continuous signal which is proportional to measured fluid pressure (processed output signal, see Paragraph [0098]), wherein the continuous signal provided by a non-visual source (processed output signal can just be the data transferred from the sensor 20 and is not a visual source). Hassan et al. (US 20110263976 A1) teaches a system for real time monitoring of catheter aspiration (injection catheter system 700, see Paragraph [0055]; Figure 7), comprising: a pressure sensor (710) configured for placement in fluid communication with a lumen which at least partially includes an aspiration lumen of a catheter (fluid collector 780 of catheter 700, see Figure 7), the aspiration lumen configured to couple to a vacuum source (aspirators having suction sources, see Paragraph [0058]); a processor coupled to the pressure sensor and configured for measuring deviations in fluid pressure (detector, not shown, see Paragraph [0055]; measuring hemodynamic signatures, see Paragraph [0055]); and a communicator coupled to the processor (processor, see Paragraph [0068]) and configured to generate a continuous signal which is proportional to measured fluid pressure (hemodynamic data having a hemodynamic curve, see Paragraph [0055]), the continuous signal provided by a non-visual source (it is understood that the continuous signal can just be data transferred to the processor and not shown as a non-visual source). Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIC RASSAVONG whose telephone number is (408)918-7549. The examiner can normally be reached Monday - Friday 9:00am-5:30pm PT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nicholas J. Weiss can be reached at (571)270-1775. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /E.R./ (9/10/2025)Examiner, Art Unit 3781 /PHILIP R WIEST/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Jul 15, 2023
Application Filed
Sep 10, 2025
Non-Final Rejection — §102, §103, §DP
Dec 19, 2025
Response Filed
Apr 04, 2026
Non-Final Rejection — §102, §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582759
Negative Pressure Charged Vibration Mechanism For Intermittent Wound Dressing Vibration
2y 5m to grant Granted Mar 24, 2026
Patent 12558251
BASE PLATE FOR AN OSTOMY APPLIANCE
2y 5m to grant Granted Feb 24, 2026
Patent 12539233
SYSTEMS, DEVICES, AND METHODS FOR REPLACING AN EYEDROPPER TIP ON AN EYEDROPPER BOTTLE WITH A REPLACEMENT EYEDROPPER TIP
2y 5m to grant Granted Feb 03, 2026
Patent 12485265
VALVES
2y 5m to grant Granted Dec 02, 2025
Patent 12458744
MULTI-CANISTER MODULE FOR NEGATIVE-PRESSURE THERAPY
2y 5m to grant Granted Nov 04, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+33.3%)
2y 5m
Median Time to Grant
Moderate
PTA Risk
Based on 152 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month